U.S. Biological Buffers Market was Valued at USD 0.38 Billion in 2025 and is Expected to Reach USD 0.70 billion by 2033 Due to Rising Biologics and Vaccine DevelopmentAustin, Jan. 20, 2026 (GLOBE ...
Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...